NCT07186660View on ClinicalTrials.gov

Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Type 1 Diabetes (T1D)Glycemic Control for Diabetes MellitusInsulinKetonesCardiovascular Health
Interventions
DRUG

CIR-0602K

mitochondrial pyruvate carrier inhibitor

DRUG

Placebo

Placebo tablet

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER